Immunosuppressive agents with intrinsic antifungal activity are emerging as candidates for drug repurposing, including calcineurin inhibitors (e.g., cyclosporine, pimecrolimus, tacrolimus/FK506), mTOR inhibitors (e.g., rapamycin), antimetabolites (e.g., mizoribine [MZP], mycophenolic acid [MPA]), and glucocorticoids
Whether you want to understand side effects better or need advice on managing them, Doctronics AI doctor synthesizes the latest peer-reviewed medical research to give you personalized, up-to-date answers in seconds
Do not take a double dose to make up for the missed injection
Novo Nordisk, meanwhile, has reported phase 3 results for its oral semaglutide already approved as Rybelsus for type 2 diabetes and with a filing in obesity due this year and it also has early-stage results for a next-generation candidate called amycretin.
It is important to discuss any new or persistent side effects with your healthcare professional when taking GLP-1 weight loss injections